Home Partnering Key areas of partnering interest
|
|
| Science & Technology Alliances |
| Key areas of partnering interest |
|
|
To do this, we are seeking to access advances in new technologies and capabilities from the external community that can be applied to enhance the quality, effec-tiveness, and productivity of AstraZeneca R&D. The Science and Technology Alliances team work across therapeutic areas and functions to identify, evaluate and secure opportunities in key areas of technology interest to AstraZeneca. | Key areas of partnering interest |
|---|
We are seeking collaborations and licensing opportunities aligned to key areas of technology interes including: Chemistry - Expanding the scope of synthetic methodology - Novel Lead Generation technologies - Predictive QSAR methodology - Synthetic scheme prediction - Membrane protein structure determination
Predictive Biology - High content screening technologies for large scale compound profiling - More physiological cell-based efficacy screening technologies (e.g. primary tissue or stem cell based) - Target validation methodology - Improved methodology for safety/toxicity prediction e.g. - in-silico simulation - in-vitro predictive models - in-vivo imaging - Biomarker identification and qualification
Predictive Medicine - In-silico disease simulation and prediction models - Rapid sequencing technology for biomarker analysis - Imaging technologies providing functional measurements of disease activity
Knowlege Management/Informatics - Structured searching and text mining tools - Patent informatics |
Contact alan.lamont@astrazeneca.com iain.comley@astrazeneca.com
|
|
|
|